- Home
- TOPS vs CVKD Comparison
TOPS vs CVKD Comparison
Compare TOPS & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- CVKD
- Stock Information
- Founded
- TOPS 2000
- CVKD 2022
- Country
- TOPS Greece
- CVKD United States
- Employees
- TOPS N/A
- CVKD N/A
- Industry
- TOPS Marine Transportation
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- TOPS Consumer Discretionary
- CVKD Health Care
- Exchange
- TOPS Nasdaq
- CVKD Nasdaq
- Market Cap
- TOPS 27.2M
- CVKD 29.5M
- IPO Year
- TOPS 2004
- CVKD 2023
- Fundamental
- Price
- TOPS $5.95
- CVKD $10.54
- Analyst Decision
- TOPS
- CVKD Strong Buy
- Analyst Count
- TOPS 0
- CVKD 1
- Target Price
- TOPS N/A
- CVKD $32.00
- AVG Volume (30 Days)
- TOPS 18.2K
- CVKD 27.7K
- Earning Date
- TOPS 08-08-2025
- CVKD 08-11-2025
- Dividend Yield
- TOPS N/A
- CVKD N/A
- EPS Growth
- TOPS N/A
- CVKD N/A
- EPS
- TOPS 1.09
- CVKD N/A
- Revenue
- TOPS $86,127,000.00
- CVKD N/A
- Revenue This Year
- TOPS $9.90
- CVKD N/A
- Revenue Next Year
- TOPS N/A
- CVKD N/A
- P/E Ratio
- TOPS $5.58
- CVKD N/A
- Revenue Growth
- TOPS 3.83
- CVKD N/A
- 52 Week Low
- TOPS $5.00
- CVKD $5.70
- 52 Week High
- TOPS $11.47
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- TOPS 46.80
- CVKD 37.37
- Support Level
- TOPS $5.91
- CVKD $11.25
- Resistance Level
- TOPS $6.36
- CVKD $11.88
- Average True Range (ATR)
- TOPS 0.36
- CVKD 0.77
- MACD
- TOPS 0.02
- CVKD -0.03
- Stochastic Oscillator
- TOPS 18.92
- CVKD 2.95
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.